HIV

Category

Duke University School of Nursing Investigators Embark on Innovative Community Study to Reduce Growing HIV Rates Among Black Women in the South

TrialSite’s Founder Daniel O’Connor recently had the honor of interviewing Duke University’s Schenita D. Randolph, PhD, MPH, RN, CNE, assistant professor, and her colleague Ragan Johnson, DNP, MSN, APRN-BC, assistant professor, in an effort to learn more...

NCI Injects $111m into NYC’s Montefiore & Einstein to Prevent & Treat HIV-Associated Cancers

Modern medicine, often a near miracle, creates more challenges to solve. For instance, the adoption worldwide of antiretroviral therapies to suppress the HIV virus has helped tens of millions of people with HIV live healthier, longer lives. However, with this...

Kaiser Permanente NorCal Research: Early Diagnosis and Treatment of HIV with ART Reduces Incidence of Cancer

New compelling research reveals that patients with HIV who are diagnosed early and placed on antiretroviral therapy (ART) show benefits, including reduced risk of certain types of cancers. The net takeaway: the earlier HIV can be diagnosed and ART introduced, the...

Innovative UNC-based Public-Private HIV Investigative Group Secures $20m & Continues its Leading ‘Induce & Reduce’ Strategy

University of North Carolina (UNC) Chapel Hill researchers and local industry scientists secured $20 million in the from of a research contract targeting a cure for HIV. The deal was executed between ViiV Healthcare and UNC at Chapel Hill to renew the unique,...

Cancer Immunotherapy Likely Safe for those with Chronic Infections Reports Georgetown University Retrospective Study

A retrospective study driven by Lombardi Comprehensive Cancer Center, MedStar Georgetown University Hospital, found that cancer patients battling viral infections such as HIV, hepatitis B virus (HBV), and hepatitis C virus (HCV) shouldn’t be precluded from immune...